Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/27862
DC FieldValueLanguage
dc.contributor.authorPanovska Stavridis, Irinaen_US
dc.contributor.authorEftimov, Aleksandaren_US
dc.contributor.authorIvanovski, Martinen_US
dc.contributor.authorStojanovic, Aleksandaren_US
dc.contributor.authorGeorgievski, Borcheen_US
dc.contributor.authorChevrevska, Lidijaen_US
dc.contributor.authorDimovski, Aleksandaren_US
dc.date.accessioned2023-09-07T10:12:12Z-
dc.date.available2023-09-07T10:12:12Z-
dc.date.issued2016-08-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/27862-
dc.description.abstractAcquired calreticulin (CALR) gene mutations are one of the molecular hallmarks of essential thrombocythemia (ET). It has been suggested that patients with ET with CALR mutations are associated with a distinct clinical phenotype.en_US
dc.language.isoenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofClinical lymphoma, myeloma & leukemiaen_US
dc.titleDiversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemiaen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.clml.2016.04.019-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S2152265016300623?httpAccept=text/xml-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S2152265016300623?httpAccept=text/plain-
dc.identifier.volume16-
dc.identifier.issue8-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

75
checked on May 4, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.